News
Therefore, lentiviral vectors may be a more appropriate and potentially superior vector system than oncoretroviral vectors for transduction of HSC, especially in short transduction protocols.
Transduction efficiency (i.e., how much of the genetic material from the packaged lentivirus is transferred and incorporated into the cell) can vary widely. Microfluidics-driven solution ...
Takara Bio Launches First Commercial Dissolvable Microfluidic Lentiviral Transduction Enhancer. May 06, 2024 08:00 AM Eastern Daylight Time. ... a world standard in gene therapy protocols.
Höfig, I. et al. Systematic improvement of lentivirus transduction protocols by antibody fragments fused to VSV-G as envelope glycoprotein. Biomaterials , March 2014 DOI: 10.1016/j.biomaterials ...
Lentiviral vectors remain a cornerstone in cell and gene therapy applications, offering high transduction efficiency and integration capability. ... this poster to learn how optimizing pH and flow ...
Learn how to overcome the challenges of viral transduction workflows. Login. Subscribe. News; Magazines. An Interactive Experience. Current Issue. June 2025. View this Issue. Archive. ... Download ...
Hosted on MSN3mon
A new strategy to enhance gene therapy for sickle cell disease - MSNAnne Galy, Ph.D., from Inserm, and co-authors, applied a novel lentivirus-based gene therapy strategy in CD34 + hematopoietic progenitor and stem cells (HSPCs) obtained from cord blood.
Lentivirus is a genus in the family of Retroviridae that is very suitable for remodeling into gene transfer vectors due to its stable transgene expression, the ability to reach the nuclei of the ...
Anne Galy, PhD, from Inserm, and coauthors, applied a novel lentivirus-based gene therapy strategy in CD34+ hematopoietic progenitor and stem cells (HSPCs) obtained from cord blood.
Takara Bio USA, Inc., a wholly owned subsidiary of Takara Bio Inc., today announced the launch of the Lenti-X™ Transduction Sponge, a first-to-market dissolvable microfluidic transduction ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results